Seeking Alpha

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the Administration ...
Nasdaq

Emergent BioSolutions Announces Exercise of $20 Million Option to Supply U.S. Department of Defense with BioThrax® (Anthrax Vaccine Adsorbed)

BioThrax® (Anthrax Vaccine Adsorbed) is a vaccine indicated for the active immunization for the prevention of disease caused by Bacillus anthracis in persons 18 through 65 years of age. BioThrax® is ...
KELOLAND News

Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense

GAITHERSBURG, Md., Jan. 11, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has secured an indefinite-delivery, indefinite-quantity (IDIQ) procurement contract ...
The Business Journals

For Emergent BioSolutions, anthrax vaccine remains the cash cow

The good news for Emergent BioSolutions Inc.: Everything is up. Revenue last year grew to $312.7 million from $281.9 million in 2012. Net income rose to $31.1 million from $23.5 million the year ...
Nasdaq

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

GAITHERSBURG, Md., March 18, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has recently secured approximately $27 million in international orders targeted for ...
The Business Journals

Emergent BioSolutions gets $186.6M deal

Rockville-based Emergent BioSolutions Inc. has received a contract worth up to $186.6 million with the Department of Health and Humans Services for development of an anthrax vaccine. Emergent ...
MarketWatch

Emergent BioSolutions Gets $21.5M Anthrax Vaccination Order From Pentagon

Emergent BioSolutions received a $21.5 million order to supply anthrax vaccinations to the Defense Department. The medical countermeasures manufacturer said Thursday that the order is under its ...
Business Insider

Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)

GAITHERSBURG, Md., Dec. 16, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that the Biomedical Advanced Research and Development Authority (BARDA) within the ...